Aveanna Healthcare Holdings Inc. (AVAH) — Financial statements
Income statement, balance sheet, and cash flow for Aveanna Healthcare Holdings Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 2,433↑20.2% | 2,025↑6.8% | 1,895↑6.0% | 1,788↑6.5% | 1,679 | |
| Cost of Revenue | 1,628↑17.2% | 1,389↑6.9% | 1,300↑5.3% | 1,234↑8.6% | 1,136 | |
| Gross Profit | 805↑26.7% | 636↑6.7% | 595↑7.6% | 553↑2.0% | 542 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 527↑12.0% | 470↑1.2% | 465↓4.0% | 484↑15.3% | 420 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 527↑12.0% | 470↑1.2% | 465↓4.0% | 484↑15.3% | 420 | |
| Other Expenses | 13↓48.4% | 25↓79.4% | 123↓82.8% | 712↑347.9% | 159 | |
| Operating Expenses | 540↑8.9% | 496↓15.6% | 587↓50.9% | 1,196↑106.7% | 579 | |
| Total Costs & Expenses | 2,168↑15.0% | 1,885↓0.1% | 1,887↓22.3% | 2,430↑41.7% | 1,715 | |
| Operating Results | ||||||
| Operating Income | 265↑89.8% | 140↑1631.8% | 8↑101.3% | -642↓1678.6% | -36 | |
| Depreciation & Amortization | 24↓23.7% | 31↑3.5% | 30↓22.5% | 39↑9.7% | 35 | |
| EBITDA | 275↑46.5% | 187↑378.4% | 39↑107.5% | -525↓2824.3% | -18 | |
| EBIT | 251↑60.5% | 156↑1622.1% | 9↑101.6% | -564↓957.1% | -53 | |
| Interest & Other Income | ||||||
| Net Interest Income | -137↑12.1% | -156↓2.1% | -153↓42.9% | -107↓55.9% | -69 | |
| Interest Income | 3↑468.5% | 0.50↑52.3% | 0.33↓51.8% | 0.68↑168.4% | 0.25 | |
| Interest Expense | 140↓10.5% | 157↑2.2% | 153↑42.3% | 108↑56.3% | 69 | |
| Non-Operating Income | 15↑188.8% | -16↓1544.3% | -1.00↑98.7% | -78↓555.0% | 17 | |
| Other Income / Expenses | -158↓17.6% | -135↑8.4% | -147↓582.8% | -22↑72.2% | -77 | |
| Income Before Tax | 107↑2008.6% | 5↑103.6% | -139↑79.1% | -664↓484.5% | -114 | |
| Income Tax Expense | -118↓838.0% | 16↑457.8% | -4↓151.2% | -2↓151.3% | 3 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 225↑2159.1% | -11↑91.9% | -135↑79.7% | -662↓465.6% | -117 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 225↑2159.1% | -11↑91.9% | -135↑79.7% | -662↓465.6% | -117 | |
| Bottom-Line Net Income | 225↑2159.1% | -11↑91.9% | -135↑79.7% | -662↓465.6% | -117 | |
| EPS (Basic) | 1.10↑2040.0% | -0.06↑92.0% | -0.71↑80.1% | -3.57↓466.7% | -0.63 | |
| EPS (Diluted) | 1.05↑1951.9% | -0.06↑92.0% | -0.71↑80.1% | -3.57↓466.7% | -0.63 | |
| Weighted Average Shares | 204↑5.5% | 193↑1.5% | 190↑2.4% | 186↑0.4% | 185 | |
| Weighted Average Diluted Shares | 215↑11.4% | 193↑1.5% | 190↑2.4% | 186↑0.4% | 185 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.